Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-255,783
Closed -$1.38M 3648
2025
Q3
$1.38M Buy
255,783
+40,660
+19% +$220K ﹤0.01% 1986
2025
Q2
$1.17M Sell
215,123
-15,690
-7% -$62.2K ﹤0.01% 2002
2025
Q1
$639K Buy
230,813
+60,941
+36% +$212K ﹤0.01% 2372
2024
Q4
$579K Hold
169,872
﹤0.01% 2528
2024
Q3
$499K Buy
169,872
+18,829
+12% +$62K ﹤0.01% 2455
2024
Q2
$514K Buy
151,043
+55,050
+57% +$180K ﹤0.01% 2319
2024
Q1
$291K Buy
95,993
+25,372
+36% +$89.1K ﹤0.01% 2628
2023
Q4
$297K Sell
70,621
-1,889
-3% -$10.2K ﹤0.01% 2655
2023
Q3
$495K Buy
72,510
+3,491
+5% +$30.8K ﹤0.01% 2183
2023
Q2
$719K Buy
69,019
+15,665
+29% +$140K ﹤0.01% 2165
2023
Q1
$372K Buy
53,354
+3,266
+7% +$28.5K ﹤0.01% 2663
2022
Q4
$302K Buy
50,088
+8,098
+19% +$59.8K ﹤0.01% 2733
2022
Q3
$331K Sell
41,990
-54,999
-57% -$641K ﹤0.01% 2629
2022
Q2
$1.32M Buy
96,989
+17,208
+22% +$285K ﹤0.01% 1989
2022
Q1
$1.56M Buy
79,781
+9,930
+14% +$198K ﹤0.01% 2041
2021
Q4
$2.4M Sell
69,851
-5,014
-7% -$202K ﹤0.01% 1887
2021
Q3
$4.09M Sell
74,865
-8,864
-11% -$534K ﹤0.01% 1626
2021
Q2
$6.15M Sell
83,729
-394,613
-82% -$39.4M ﹤0.01% 1407
2021
Q1
$43.7M Buy
478,342
+349,603
+272% +$33.9M 0.02% 635
2020
Q4
$10.4M Buy
128,739
+33,409
+35% +$2.56M 0.01% 1016
2020
Q3
$4.44M Buy
+95,330
New +$5.32M ﹤0.01% 1312

Other funds holding CVAC

Deutsche Bank's CVAC Position: Q4 2025 in Review

Deutsche Bank sold out of CureVac (CVAC) in Q4 2025, closing a stake of 255,783 shares — an estimated $1.38M sold.

Deutsche Bank first reported a position in CVAC in Q3 2020 and held it in 21 quarters. The position peaked at $43.7M in Q1 2021. 57 funds tracked by Wall St. Rank hold CVAC as of Q4 2025.

  • Deutsche Bank reported no remaining CureVac position as of Q4 2025 after selling out during the quarter.
  • Deutsche Bank sold 255,783 CureVac shares in Q4 2025, an estimated $1.38M.
  • Deutsche Bank first reported a position in CureVac in Q3 2020 and held it in 21 quarters.
  • Deutsche Bank's CureVac position peaked at $43.7M in Q1 2021.
  • 57 funds tracked by Wall St. Rank held CureVac as of Q4 2025.

Based on Deutsche Bank's 13F filing for Q4 2025, filed 11 Feb 2026.